| POSTER WALKING TOUR Angiogenesis Hall C |
| 14:00 616. New MRI Contrast Agent for Labeling of Tumor-Associated Macrophages that Stimulate Tumor Angiogenesis, S.E. Harms, T. Hinton, L. Manning and S. Korourian, University of Arkansas for Medical Sciences and Little Rock VA Hospital, Little Rock, AR, USA. |
| 14:04 617. Characterization of DR2*/DR2 for the Evaluation of Angiogenesis Induced Changes in Vascular Morphology, A.P. Pathak, R.J. Linderman, H. Xu, B.D. Ward, A.S. Greene and K.M. Donahue, Marquette University and Medical College of Wisconsin, Milwaukee, WI, USA. |
| 14:08 618. Quantification of Endothelial Permeability, Leakage Space and Blood Volume in Brain Tumors Using Combined T1 and T2* Contrast-Enhanced Dynamic MR Imaging, X.P. Zhu, K.L. Li, I.D. Kamaly-Asl, D.R. Checkley, J.J.L. Tessier, J.C. Waterton and A. Jackson, University of Manchester, Manchester, UK and AstraZeneca, Macclesfield, Cheshire, UK. |
| 14:12 619. Parametric Mapping of Scaled Fitting Error in Dynamic Susceptibility Contrast Enhanced MR Perfusion Imaging. Part II: Clinical Application, A. Jackson, X.P. Zhu, A. Kassner, Y. Watson and K.L. Li, University of Manchester, Manchester, UK and Philips Medical Systems, Hammersmith, London, UK. |
| 14:16 620. Analysis of Perfusion MRI in Cerebral Glioma Using a Linear Filter, D.J. Peck, T. Mikkelsen, R. VanHulle, L. Scapace and D. Hearshen, Henry Ford Hospital, Detroit, MI, USA. |
| 14:20 621. Temporal Sampling Requirements for the Estimation of Blood Flow, Blood Volume and Extraction Ratio from Dynamic Contrast-Enhanced MRI Studies, T-Y. Lee, E. Henderson and B.K. Rutt, St. Joseph's Health Centre; The University of Western Ontario and Robarts Research Institute, London, ON, Canada. |
| 14:24 622. Angiogenesis in Cerebral Gliomas: T2* rCBV Map versus Pathological Vascularity, M-L. Wu, W-C. Wu, C-W. Ko, C-Y. Chen and H-W. Chung, National Taiwan University and Tri-Service General Hospital, Taipei, Taiwan, ROC. |
| 14:28 623. Tumor Oxygen Dynamics with Respect to Growth and Respiratory Challenge by 19F NMR EPI, D. Zhao, A. Constantinescu, E.W. Hahn and R.P. Mason, University of Texas, Southwestern Medical Center, Dallas, TX, USA. |
| 14:32 624. Assessing Tumour Response to Treatment: Histogram Analysis of Parametric Maps of Tumour Vascular Function Derived From Dynamic Contrast-Enhanced MR Images, C. Hayes, A.R. Padhani and M.O. Leach, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK. |
| 14:36 625. Assessment of Human Tumor Response to a Vascular Targeting Agent Through Contrast-Enhanced MRI Perfusion Measurement, N. Rafie, J.A. Jesberger, J.L. Duerk, M. Mendez, S.C. Remick and J.S. Lewin, Case Western Reserve University, Cleveland, OH, USA. |